VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
Use this VTGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VTGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VTGN SEC filings page. Lician reads the product cache first so this HTML stays unique to VistaGen Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VTGN income, balance, and cash tables.